Authors Affiliations: Department of Biobehavioral Nursing Science, College of Nursing, University of Florida, Gainesville (Drs Dyal, Duckworth, Yao, Wilkie, and Ezenwa and Mss Abudawood, Schoppee, Jean, Smith, Greenlee, and Staton); King Saud bin Abdulaziz University for Health Sciences Scholar, Jeddah, Saudi Arabia (Ms Abudawood); and Community Hospice and Palliative Care, Jacksonville (Ms Schoppee); and Center for Palliative Care Research & Education (Drs Wilkie, Ezenwa, Yao, Duckworth, Dyal, Black, and Mandernach and Mss Schoppee, Jean, Smith, Greenlee, and Staton) and Division of Hematology/Oncology, Department of Pediatrics (Dr Black), and Department of Medicine (Drs Heldermon and Mandernach), College of Medicine, University of Florida, Gainesville.
V.B. received funds from NHLBI, Pfizer, and Sancilio and Company; V.B. also has consulted for Prolong Pharmaceuticals and Bioverativ. M.O.E. received funds provided by the University of Florida College of Nursing and the Center for Palliative Care Research & Education. D.J.W. is the director, Center for Palliative Care Research & Education, and the chairman and founder of eNURSING llc, a company with no relationship to the study. The other authors have no funding or conflicts of interest to disclose.
B.W.D. and K.A. contributed equally to this work.
Correspondence: Brenda W. Dyal, PhD, DNP, APRN, FNP-BC, College of Nursing, University of Florida, 1225 Center Dr, Gainesville, FL 32610 ([email protected]).
Accepted for publication July 5, 2019.
